Terms: = Sarcomas AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
130 results:
1. Phase separation of SHP2E76K promotes malignant transformation of mesenchymal stem cells by activating mitochondrial complexes.
Kan C; Tan Z; Liu L; Liu B; Zhan L; Zhu J; Li X; Lin K; Liu J; Liu Y; Yang F; Wong M; Wang S; Zheng H
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38451719
[TBL] [Abstract] [Full Text] [Related]
2. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
[TBL] [Abstract] [Full Text] [Related]
3. Exploration in the Mechanism of Ginsenoside Rg5 for the treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.
Liu MY; Jiang DX; Zhao X; Zhang L; Zhang Y; Liu ZD; Liu RZ; Li HJ; Rong XY; Gao YZ
Orthop Surg; 2024 Feb; 16(2):462-470. PubMed ID: 38086608
[TBL] [Abstract] [Full Text] [Related]
4. From bench to bedside: current development and emerging trend of KRAS-targeted therapy.
Chen Y; Liu QP; Xie H; Ding J
Acta Pharmacol Sin; 2024 Apr; 45(4):686-703. PubMed ID: 38049578
[TBL] [Abstract] [Full Text] [Related]
5. A multiomic investigation of lung adenocarcinoma molecular subtypes.
Liang KH; Luo YH; Wang ML; Chiou SH; Chen YM; Hsu HS
J Chin Med Assoc; 2024 Jan; 87(1):33-39. PubMed ID: 37991388
[TBL] [Abstract] [Full Text] [Related]
6. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
7. Identification of a Novel, Potent, and Orally Bioavailable Guanidine-Based SHP2 Allosteric Inhibitor from Virtual Screening and Rational Structural Optimization for the treatment of KRAS Mutant Cancers.
Hou Q; Jiang W; Li W; Huang C; Yang K; Chen X; Huang M; Shu C; Luo G; Sun H; Chu Q; Wu X
J Med Chem; 2023 Oct; 66(19):13646-13664. PubMed ID: 37754066
[TBL] [Abstract] [Full Text] [Related]
8. Network pharmacology and molecular docking to explore the mechanism of Sheng Xue Bao mixture against iron deficiency anemia.
Wang Y; Qinqin H; Wang H; Zhang H; Zhang X; Liu W; Xiang Z; Gu Y
Medicine (Baltimore); 2023 Sep; 102(37):e35012. PubMed ID: 37713882
[TBL] [Abstract] [Full Text] [Related]
9. Intensified Adjuvant treatment for High-Risk Resected Cutaneous Angiosarcoma of the Head and Neck.
El Shatanofy M; Thakkar P; Patel V; Joshi A; Goodman J; Siegel R; Haroun F; Ojong-Ntui M; Goyal S; Bauman J; Rao YJ
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1225-1233. PubMed ID: 37464928
[TBL] [Abstract] [Full Text] [Related]
10. v-src delocalizes Aurora B by suppressing Aurora B kinase activity during monopolar cytokinesis.
Ota R; Watanabe T; Wazawa Y; Kuwajima H; Honda T; Soeda S; Saito Y; Yuki R; Fukumoto Y; Yamaguchi N; Yamaguchi N; Nakayama Y
Cell Signal; 2023 Sep; 109():110764. PubMed ID: 37315749
[TBL] [Abstract] [Full Text] [Related]
11. E7050 Suppresses the Growth of Multidrug-Resistant Human Uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways.
Huang TT; Chen CM; Lin SS; Lan YW; Cheng HC; Choo KB; Wang CC; Huang TH; Chong KY
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298555
[TBL] [Abstract] [Full Text] [Related]
12. Traditional Chinese Medicine Targeting Sarcoma Virus Oncogene-related Diseases.
Wang Y; Wang X; Su K; Yang Y
Curr Cancer Drug Targets; 2023; 23(10):751-763. PubMed ID: 37170983
[TBL] [Abstract] [Full Text] [Related]
13. Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing.
Kamolphiwong R; Kanokwiroon K; Wongrin W; Chaiyawat P; Klangjorhor J; Settakorn J; Teeyakasem P; Sangphukieo A; Pruksakorn D
Gene; 2023 Mar; 856():147106. PubMed ID: 36513192
[TBL] [Abstract] [Full Text] [Related]
14. Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells.
Huang TT; Chen CM; Lan YW; Lin SS; Choo KB; Chong KY
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499211
[TBL] [Abstract] [Full Text] [Related]
15. Research of the Active Components and Potential Mechanisms of Qingfei Gujin Decoction in the treatment of Osteosarcoma Based on Network Pharmacology and Molecular Docking Technology.
Yan Q; Yang J; Yao Y; Jia Z; Wang Y; Cheng M; Yan X; Xu Y
Comput Math Methods Med; 2022; 2022():7994425. PubMed ID: 36466554
[TBL] [Abstract] [Full Text] [Related]
16. Material basis and integrative pharmacology of danshen decoction in the treatment of cardiovascular diseases.
Liu M; Li Z; Ouyang Y; Chen M; Guo X; Mazhar M; Kang J; Zhou H; Wu Q; Yang S
Phytomedicine; 2023 Jan; 108():154503. PubMed ID: 36332387
[TBL] [Abstract] [Full Text] [Related]
17. Synergistic effect of growth factor receptor-bound protein 2/epidermal growth factor receptor dual-targeting peptide inhibitor and salinomycin on osteosarcoma.
Yu Z; Xu Y; Du L; Zhang F; Shao M; Xie L; Cai G; Lyu F
J Cancer Res Ther; 2022 Apr; 18(2):352-361. PubMed ID: 35645100
[TBL] [Abstract] [Full Text] [Related]
18. Computational analysis of cortical neuronal excitotoxicity in a large animal model of neonatal brain injury.
Kratimenos P; Vij A; Vidva R; Koutroulis I; Delivoria-Papadopoulos M; Gallo V; Sathyanesan A
J Neurodev Disord; 2022 Mar; 14(1):26. PubMed ID: 35351004
[TBL] [Abstract] [Full Text] [Related]
19. Hexachlorophene, a selective SHP2 inhibitor, suppresses proliferation and metastasis of KRAS-mutant NSCLC cells by inhibiting RAS/MEK/ERK and PI3K/AKT signaling pathways.
Fu NJ; Xi RY; Shi XK; Li RZ; Zhang ZH; Li LY; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2022 Apr; 441():115988. PubMed ID: 35307375
[TBL] [Abstract] [Full Text] [Related]
20. Nectin cell adhesion molecule 4 regulates angiogenesis through src signaling and serves as a novel therapeutic target in angiosarcoma.
Tanaka Y; Murata M; Tanegashima K; Oda Y; Ito T
Sci Rep; 2022 Mar; 12(1):4031. PubMed ID: 35256687
[TBL] [Abstract] [Full Text] [Related]
[Next]